Investor Discover
Menu
Log inStart Free Trial
← Publication
Investor Discover Team12 min readFundraising

The Founder's Guide to Valuation: How to Justify Your Number to Investors

Picking a valuation out of thin air is one of the fastest ways to lose credibility in a fundraise. Here is how to build a number you can defend.

Financial charts and data analysis on a screen

Valuation is one of the most loaded conversations in a fundraise - and one of the most misunderstood. Founders often treat it as a negotiating position: start high, expect pushback, land somewhere in the middle. Experienced investors see through this immediately. A number you cannot defend signals that you do not understand your own business well enough to be given capital.

The founders who close rounds fastest are not the ones who ask for the highest number or the lowest - they are the ones who walk in with a justification. Three methods form the foundation of any credible valuation conversation at seed and Series A stage.

Method 1: comparable transactions

The first method investors respect is comparable transactions. What have similar companies raised at, at a similar stage, in a similar market, in the last 12 to 18 months? Comparable means comparable - same revenue range, same sector, similar team profile. A consumer app cannot use a B2B SaaS comp. A pre-revenue company cannot benchmark against a Series A. The more specific your comps, the stronger your position.

Sources for comparable transactions include Crunchbase, AngelList, PitchBook if you have access, and investor portfolio pages. Look for announced rounds, not just company names - many early rounds are not publicly disclosed. When you find a valid comp, note the ARR or stage at time of raise, the round size, and the lead investor. Three to five solid comps are more convincing than ten weak ones.

If an investor challenges your comps, do not back down immediately. Ask which comps they would use. This shifts the conversation from whether your number is defensible to what the right reference points are - which is a much more productive negotiation.

Method 2: revenue multiples

For companies with meaningful ARR, seed and Series A valuations typically range from 10x to 40x ARR depending on growth rate, sector, and market conditions. A company doing $200K ARR growing at 15% month-over-month in a large market can justify a higher multiple than one doing $500K ARR growing at 3%. The multiple is not arbitrary - it reflects expected future growth.

If you use a revenue multiple, know your growth rate cold and be prepared to defend why it will hold. Investors will model your ARR forward 18 to 24 months and compare the implied valuation at your next round against what they are paying today. If the math does not give them a reasonable return path, the multiple will not hold regardless of how strong your comparables are.

Revenue growth chart on a screen
Investors model your next round when they evaluate this one. The implied return at exit shapes how they think about your current valuation.

Method 3: milestone-based framing

Rather than anchoring to a multiple, you justify your valuation by the milestone the capital will fund and what that milestone implies about the next round. 'We are raising $1.5M at a $6M pre-money to reach $1M ARR, at which point we expect a Series A at 15-20x - implying a $15-20M valuation and a 2.5-3x step up for seed investors.' This framing shows capital discipline, a clear outcome, and an understanding of what your investors need to see to make their model work.

Milestone framing works especially well for pre-revenue or early-revenue companies where multiples are hard to anchor and comps are scarce. It reframes the valuation question from 'what is the company worth today' to 'what will this company be worth when this capital is deployed' - which is the question investors are actually trying to answer.

How Buffer approached valuation transparency

Buffer's Series A: how radical transparency shaped their valuation conversation

2014

Series A

$3.5M

~$3.6M

Buffer, the social media scheduling company founded by Joel Gascoigne and Leo Widrich, took an unusual approach to their Series A fundraise in 2014: they made their revenue, growth rate, and valuation thinking publicly available on their blog throughout the process.

At the time of their raise, Buffer had approximately $3.6M in ARR and was growing at around 10% month-over-month. Gascoigne published their reasoning for their valuation ask directly: they used a revenue multiple benchmarked against comparable SaaS companies at similar growth rates, adjusted for their capital efficiency (they had been largely bootstrapped until this point) and their market size.

The transparency served a dual purpose. It attracted investors who were aligned with their philosophy - they ended up closing the round with investors who valued the openness and were less likely to create friction later. It also eliminated the valuation negotiation almost entirely: by the time investors came to the table, they had already seen the reasoning and could engage with the methodology rather than just the number.

Buffer raised $3.5M at a valuation that implied roughly a 10x ARR multiple - conservative by 2021 standards but appropriate for the market conditions in 2014. More importantly, they closed in a relatively short time frame for a Series A because there was no information asymmetry to overcome.

The broader lesson is not that every founder should publish their financials. It is that founders who can explain their valuation methodology clearly - whether publicly or in a meeting - create a fundamentally different dynamic than those who present a number and wait to be challenged. Confidence in the reasoning is more persuasive than confidence in the number.

Terms matter as much as the headline number

Anti-dilution provisions, pro-rata rights, and liquidation preferences all affect what your valuation actually means in an exit scenario. A high headline valuation with a 2x participating liquidation preference can leave founders with less at exit than a lower valuation with clean terms. Always model the exit waterfall, not just the entry valuation.

Contract and legal documents on a desk
The term sheet is not just a valuation document. Every clause affects what founders and early investors actually receive at exit.

The cleanest term sheets at seed are typically: no participating preferred (straight preferred is standard), 1x non-participating liquidation preference, standard pro-rata rights for the lead investor, and a reasonable option pool. Any deviation from this baseline - a participating liquidation preference, a ratchet, aggressive anti-dilution - should be understood fully before you sign, not explained to you by a lawyer after the fact.

Calibrating your ask

One practical calibration: if every investor you pitch says yes to your valuation without hesitation, you are probably priced too low. If most say no and cite valuation as the issue, you are probably too high. Two or three investors who engage seriously but push back on price is the signal you are in the right range - that is the conversation where terms get made.

Do not adjust your valuation after every conversation. Pick a number with a method, go to market with it, and use the first ten meetings to calibrate. Make one adjustment if needed and hold it. Founders who reprice constantly signal that their number was not anchored to anything in the first place.

Investor Discover helps you identify investors who are active at your investment stage and match your investment interest - which means when you pitch your valuation, you are pitching to someone who already has conviction in the market. A well-targeted list is as important as a well-justified number.

Next step: shortlist investors

Segment the dataset by investment stage, investment interest, and location, then access verified contacts and exports on subscription.